BDBM312875 US9605005, Example 165::ethyl 3-carbamoyl-1-[4-[2-[(3R)- 3-hydroxy-1-methyl-2-oxo- pyrrolidin-3-yl]ethynyl]-2- pyridyl]-6,7-dihydro-4H-pyra- zolo[4,3-c]pyridine-5-car- boxylate
SMILES: CCOC(=O)N1CCc2c(C1)c(nn2-c1cc(ccn1)C#C[C@]1(O)CCN(C)C1=O)C(N)=O
InChI Key: InChIKey=LHCNLDWJZUTOGA-QFIPXVFZSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Inhibitor of nuclear factor kappa-B kinase subunit beta (Homo sapiens (Human)) | BDBM312875 (US9605005, Example 165 | ethyl 3-carbamoyl-1-[4-[2...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 0.230 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Genentech, Inc. US Patent | Assay Description The ability of the nuclear factor-kappa B (NF-kB)-inducing kinase (NIK) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) was monit... | US Patent US9605005 (2017) BindingDB Entry DOI: 10.7270/Q2T43W61 | |||||||||||
More data for this Ligand-Target Pair |